











Bridging the gap between conventional pharmaceuticals and AI-powered digital therapeutics, we integrate personalized medication with real-time lifestyle interventions.
A global epidemic affecting over 650 million adults, with a treatment market exceeding $250 billion.
Age-related muscle loss affecting millions, with a projected market potential of $50 billion by 2050.
Musculoskeletal disorders affecting 1.7 billion people, with healthcare costs exceeding $200 billion.
Hanmi Pharmaceutical is developing patient-tailored obesity treatments integrated with digital therapeutics.
Let’s craft your digital masterpiece together.